INHIBITION OF VASCULAR SMOOTH-MUSCLE CELL-GROWTH THROUGH ANTISENSE TRANSCRIPTION OF A RAT INSULIN-LIKE GROWTH-FACTOR-I RECEPTOR CDNA

被引:74
作者
DU, J [1 ]
DELAFONTAINE, P [1 ]
机构
[1] EMORY UNIV,DEPT MED,DIV CARDIOL,ATLANTA,GA 30322
关键词
INSULIN-LIKE GROWTH FACTOR I; MOLECULAR CLONING; ANTISENSE RNA; TRANSFECTION; CELLULAR PROLIFERATION;
D O I
10.1161/01.RES.76.6.963
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Insulin-like growth factor I (IGF I) is an autocrine/paracrine growth factor that is produced in multiple tissues and is essential for normal developmental growth. Its effects are mediated by activation of a membrane-bound tyrosine kinase receptor, IGF IR. On the basis of the partial rat IGF IR alpha-chain cDNA sequence previously reported, we cloned cDNA encoding the full-length rat IGF IR. The deduced amino acid sequence predicts a 1370-amino acid receptor precursor, which includes signal sequence, a 707-amino acid alpha-chain, a 4-Arg cleavage site, and a 629-amino acid beta-chain. Overall, similarity to human IGF IR is 89% and 98% at the nucleotide and amino acid levels, respectively. Antisense IGF IR expression constructs in vectors incorporating Epstein-Barr virus replicative signals and the cytomegalovirus promoted-enhancer or the inducible human metallothionein IIa promoterienhancer were assembled and stably transfected into cultured rat aortic smooth muscle cells. Clone CA9 (constitutively expressing abundant antisense IGF IR transcripts), clones MA5 and MA7 (expressing antisense IGF IR transcripts inducibly), and clones ME8 and ME10 (expressing vector alone) were characterized. There was a 57% reduction in IGF IR mRNA levels in clone CA9 after confluence compared with clone ME10. This resulted in a 51% decrease in IGF I binding sites in clone CA9, without a change in binding affinity (K-d), and a 55% and 57% reduction in DNA synthesis rates, basally and in response to 10 ng/mL IGF I, respectively. Clones MA5/MA7 similarly showed a 54% reduction in IGF IR number after confluence following exposure to 100 mu mol/L ZnSO4 and a 44% and 58% reduction in DNA synthesis, basally and in response to 10 ng/mL IGF I, respectively. Growth curves indicated that proliferation of clone CA9 in the presence of 10% serum was reduced by 60% compared with clone ME10. Thus, cloning of cDNA encoding the full-length rat IGF IR indicates that this receptor is highly conserved. Antisense targeting of this receptor in vascular smooth muscle cells (VSMCs) demonstrates that a decrease in IGF IR density results in marked inhibition of VSMC proliferation. These findings indicate an important role for this ligand-receptor system in regulating VSMC growth. Specifically, they suggest that modulation of VSMC IGF IR density may be an important mechanism whereby growth of these cells is controlled.
引用
收藏
页码:963 / 972
页数:10
相关论文
共 60 条
  • [1] ANKRAPP DP, 1993, CANCER RES, V53, P3399
  • [2] [Anonymous], 1991, INSULIN LIKE GROWTH
  • [3] BLOCKADE OF THE TYPE-I SOMATOMEDIN RECEPTOR INHIBITS GROWTH OF HUMAN-BREAST CANCER-CELLS IN ATHYMIC MICE
    ARTEAGA, CL
    KITTEN, LJ
    CORONADO, EB
    JACOBS, S
    KULL, FC
    ALLRED, DC
    OSBORNE, CK
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) : 1418 - 1423
  • [4] INSULIN-LIKE GROWTH FACTOR-I IS AN AUTOCRINE REGULATOR OF HUMAN COLON CANCER CELL-DIFFERENTIATION AND GROWTH
    BAGHDIGUIAN, S
    VERRIER, B
    GERARD, C
    FANTINI, J
    [J]. CANCER LETTERS, 1992, 62 (01) : 23 - 33
  • [5] BAIER TG, 1992, LEUKEMIA RES, V6, P807
  • [6] BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O
  • [7] BINDING AND BIOLOGICAL EFFECTS OF INSULIN, INSULIN ANALOGS AND INSULIN-LIKE GROWTH-FACTORS IN RAT AORTIC SMOOTH-MUSCLE CELLS - COMPARISON OF MAXIMAL GROWTH-PROMOTING ACTIVITIES
    BORNFELDT, KE
    GIDLOF, RA
    WASTESON, A
    LAKE, M
    SKOTTNER, A
    ARNQVIST, HJ
    [J]. DIABETOLOGIA, 1991, 34 (05) : 307 - 313
  • [8] RECEPTORS FOR INSULIN-LIKE GROWTH FACTOR-I IN PLASMA-MEMBRANES ISOLATED FROM BOVINE MESENTERIC-ARTERIES
    BORNFELDT, KE
    ARNQVIST, HJ
    DAHLKVIST, HH
    SKOTTNER, A
    WIKBERG, JES
    [J]. ACTA ENDOCRINOLOGICA, 1988, 117 (04): : 428 - 434
  • [9] CHEN CA, 1988, BIOTECHNIQUES, V6, P632